DEREK MICHAEL FINE, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D52470
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-0670
Personal information
See more information about DEREK MICHAEL FINE at radaris.comName
Address
Phone
11402 Gunpowder Dr, Fort Washington, MD 20744
1890 Trudeau Dr, Forest Hill, MD 21050
3507 Bonfield Rd, Baltimore, MD 21208
Baltimore, MD
3507 Bonfield Rd, Pikesville, MD 21208
Professional information
Derek Michael Fine, Baltimore MD
Specialties:
Nephrologist
Address:
1830 E Monument St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Dr. Derek M Fine - MD (Doctor of Medicine)
Hospitals:
601 N Caroline St, Baltimore 21287
601 N Caroline St, Baltimore 21287
601 N Caroline St, Baltimore 21287
Education:
Medical Schools
Johns Hopkins University School Of Medicine
Graduated: 1994
Johns Hopkins University School Of Medicine
Graduated: 1994
Automated Non-Invasive Real-Time Acute Renal Failure Detection System
US Patent:
2006010, May 11, 2006
Filed:
Apr 22, 2005
Appl. No.:
11/113212
Inventors:
Seth Townsend - Skaneateles NY, US
Christopher Komanski - Orlando FL, US
Richard Boyer - Cooper City FL, US
Nathan Tedford - Somerville MA, US
Derek Fine - Baltimore MD, US
Robert Star - Bethesda MD, US
Christopher Komanski - Orlando FL, US
Richard Boyer - Cooper City FL, US
Nathan Tedford - Somerville MA, US
Derek Fine - Baltimore MD, US
Robert Star - Bethesda MD, US
Assignee:
Renal Diagnostic Inc. - Cambridge MA
International Classification:
G05D 21/00
US Classification:
700266000
Abstract:
A real-time, non-invasive system and method for determining the level of an analyte of interest in the urine of a patient is disclosed. The system and method uses the measured level of an analyte of interest to detect the onset of acute renal failure (ARF) as early as possible to prevent that patient from developing the disease or mitigating the effects of the disease. The system and method may be used to monitor the recovery of a patient after an ARF diagnosis. Preferably, the analyte of interest is creatinine or urea. The system may be placed in the urine drain line of a patient between a Foley catheter or other urinary drain and a urine collection bag. The system makes substantially continuous measurements of the urine flow rate and the concentration of the analyte of interest to determine the mass excretion rate of the analyte so it may be monitored to detect if the patient experiences a delta change in the mass excretion rate of an analyte that is indicative of the onset of ARF or a change in renal function.